Imtiaz Muhammad, Saha Biplab, Sana Ullah Uzma, Saha Aditi
Division of Pulmonary and Critical Care Medicine, Conemaugh Memorial Medical Center, Johnstown, Pennsylvania, USA.
Division of Pulmonary and Critical Care Medicine, Albany Medical Center, Albany, New York, USA.
Case Rep Pulmonol. 2019 May 20;2019:8137648. doi: 10.1155/2019/8137648. eCollection 2019.
We report a case of alveolar hemorrhage secondary to inhalation of synthetic cannabinoid. The patient developed hemoptysis and respiratory failure 48 hours after the episode. Alveolar hemorrhage from synthetic cannabinoid use is a rare entity that has been reported only thrice previously. The unique feature of this case was that the initial urine and blood toxicology screens were negative for cannabinoids and the diagnosis was confirmed via detection of serum metabolites of a synthetic cannabinoid.
我们报告一例因吸入合成大麻素继发肺泡出血的病例。患者在该事件发生48小时后出现咯血和呼吸衰竭。使用合成大麻素导致的肺泡出血是一种罕见病症,此前仅报道过三例。该病例的独特之处在于,最初的尿液和血液毒理学筛查大麻素呈阴性,通过检测合成大麻素的血清代谢物确诊。